Aminoguanidine bicarbonate
CAS: 2582-30-1
Ref. 3D-FA33808
100g | Discontinued | ||
250g | Discontinued | ||
500g | Discontinued |
Product Information
- Guanylhydrazine hydrogencarbonateAminoguanidine hydrogencarbonate
- 1-Aminoguanidine Carbonate
- 1-Aminoguanidine bicarbonate
- 1-Aminoguanidine hydrogen carbonate
- Amino guanidine bicarbonate:
- Aminoguanidine carbonate (1:1)
- Aminoguanidine carbonic acid
- Aminoguanidine hicarbonate
- Aminoguanidine hydrogen carbonate
- Aminoguanidinium Hydrogen Carbonate
- See more synonyms
- Aminoguanidinium bicarbonate
- Aminoguanidinium carbonate
- Ba 51-090222
- Carbonic Acid - Carbonohydrazonic Diamide (1:1)
- Carbonic acid, compd. with aminoguanidine (1:1)
- Carbonic acid, compd. with hydrazinecarboximidamide (1:1)
- Guanidine, amino-, bicarbonate
- Guanidine, amino-, carbonate (1:1)
- Guanidine, amino-, hydrogen carbonate
- Hydrazinecarboximidamide, carbonate (1:1)
- N<sup>1</sup>-Aminoguanidine carbonate (1:1)
- NSC 7887
Aminoguanidine is a pharmaceutical drug that has been used for the treatment of chronic renal failure and congestive heart failure. It has also been studied for its potential use in Alzheimer's disease. Aminoguanidine bicarbonate (AGBA) is the most commonly used form of aminoguanidine in clinical trials. AGBA can be synthesized by reacting malonic acid with hydrochloric acid and copper metal hydroxide, which produces copper complexes and aminoguanidine bicarbonate. AGBA inhibits the production of inflammatory cytokines, such as tumor necrosis factor-α and interleukins, and activates endothelial nitric oxide synthase, leading to vasodilation and inhibition of platelet aggregation.